COMBINING BEHAVIORAL TREATMENTS WITH AGONIST MAINTENANCE

行为治疗与激动剂维持相结合

基本信息

  • 批准号:
    6378602
  • 负责人:
  • 金额:
    $ 15.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-09-30 至 2003-08-31
  • 项目状态:
    已结题

项目摘要

This is a competing renewal of our 2x2 study evaluating methadone vs. buprenorphine and the Community Reinforcement Approach (CRA) with and without Contingency Management (CM) for the treatment of patients with concurrent opioid and cocaine dependence. Data analyses showed significantly greater improvements for methadone vs. buprenorphine and limited efficacy of CM, with a rebound in drug use after the value of the vouchers was reduced to a nominal level. Limitations of CRA and CM with opiate agonist maintained patients identified in this and other studies include the low motivation of patients to address problems of cocaine use; difficulties implementing the multifaceted and complex treatment; and the limited efficacy of CM. Therefore, we are proposing a Stage I study for manual development and pilot testing of a behavioral and social-learning theory based treatment for agonist maintained patients with combined opioid and cocaine dependence that addresses several weaknesses of CRA and CM in this population. This treatment, referred to as Therapeutic Contracting (TC), combines core aspects of the Community Reinforcement Approach (CRA) associated with improved outcome in the current study and cognitive and social learning theory based techniques which can serve as alternatives to CM for enhancing patients motivation, overcoming demoralization, and improving goal achievement. In the proposed study, we plan first to refine TC and develop an individual therapy manual and training materials for it during pre-pilot testing in 10 methadone maintained patients with combined opioid and cocaine dependence. During the pre-pilot, we also plan to develop TC adherence and competence rating scales. Subsequently, we plan to conduct a pilot study using a dismantling design to compare TC and one of its components, manual-guided cognitive-behavioral coping skills therapy (CBT). For the pilot, 3-5 therapists will be trained to administer each of the treatments and patients will be randomly assigned to 24 weeks of either TC or CBT. Primary outcome measures include reductions in illicit opioid and cocaine use and achievement of abstinence from them, as assessed by three times per week urine toxicology tests and self-report. The pilot study will be used to estimate the potential effect size of the difference between these two treatments and to evaluate the feasibility of comparing TC and CBT in a larger Stage II study. Feasibility will be evaluated by assessing whether therapists can be trained to adhere to the manuals and administer the treatments competently; whether patients can be retained in the treatments; and whether the treatments can be reliably discriminated by raters blinded to treatment assignment.
这是我们的2x2研究的竞争性更新,该研究评价了美沙酮与丁丙诺啡以及社区强化方法(CRA)联合和不联合应急管理(CM)治疗阿片类药物和可卡因同时依赖的患者。 数据分析显示,美沙酮与丁丙诺啡相比有更大的改善,CM的疗效有限,在代金券的价值降低到名义水平后,药物使用出现反弹。 在本研究和其他研究中确定的使用阿片类激动剂维持患者的CRA和CM的局限性包括患者解决可卡因使用问题的动机低;难以实施多方面和复杂的治疗;以及CM的疗效有限。 因此,我们提出了一项第一阶段研究,手动开发和试点测试的行为和社会学习理论为基础的治疗激动剂维持患者阿片类药物和可卡因的依赖,解决了CRA和CM在这一人群中的几个弱点。 这种治疗被称为治疗性合同(TC),结合了社区强化方法(CRA)的核心方面,与当前研究中的改善结果以及基于认知和社会学习理论的技术相关,这些技术可以作为CM的替代方案,用于增强患者的动力,克服士气低落,并提高目标实现。 在拟议的研究中,我们计划首先完善TC,并制定一个单独的治疗手册和培训材料,它在10美沙酮维持阿片类药物和可卡因联合依赖患者的预试点测试。在试点前,我们还计划制定遵守技术合作和能力评级量表。 随后,我们计划进行一项试点研究,使用拆卸设计,比较TC和它的组成部分之一,手动指导的认知行为应对技能疗法(CBT)。 对于试点,3-5名治疗师将接受培训,以管理每种治疗,患者将被随机分配到24周的TC或CBT。 主要结果指标包括减少非法阿片类药物和可卡因的使用,并通过每周三次尿液毒理学测试和自我报告进行评估。 初步研究将用于估计这两种治疗之间差异的潜在效应量,并评价在更大规模的II期研究中比较TC和CBT的可行性。将通过评估治疗师是否能够接受培训以遵守手册并胜任治疗;患者是否能够继续接受治疗;以及对治疗分配设盲的评定者是否能够可靠地区分治疗来评价可行性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard S Schottenfeld其他文献

Richard S Schottenfeld的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard S Schottenfeld', 18)}}的其他基金

Pain and Opioid Dependence (POD)
疼痛和阿片类药物依赖 (POD)
  • 批准号:
    7892325
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Pain and Opioid Dependence (POD)
疼痛和阿片类药物依赖 (POD)
  • 批准号:
    8081711
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Pain and Opioid Dependence (POD)
疼痛和阿片类药物依赖 (POD)
  • 批准号:
    8263984
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Pain and Opioid Dependence (POD)
疼痛和阿片类药物依赖 (POD)
  • 批准号:
    7730502
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
HIV Risk Reduction and Drug Abuse Treatment in Malaysia
马来西亚的艾滋病毒风险降低和药物滥用治疗
  • 批准号:
    6651438
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:
HIV Risk Reduction and Drug Abuse Treatment in Malaysia
马来西亚的艾滋病毒风险降低和药物滥用治疗
  • 批准号:
    6523387
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
马来西亚的药物咨询和戒毒者带回家丁丙诺啡
  • 批准号:
    7924609
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:
HIV Risk Reduction and Drug Abuse Treatment in Malaysia
马来西亚的艾滋病毒风险降低和药物滥用治疗
  • 批准号:
    6442237
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
马来西亚的药物咨询和戒毒者带回家丁丙诺啡
  • 批准号:
    7496644
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:
Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia
马来西亚的药物咨询和戒毒者带回家丁丙诺啡
  • 批准号:
    8134446
  • 财政年份:
    2001
  • 资助金额:
    $ 15.54万
  • 项目类别:

相似海外基金

Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries
阐明丁丙诺啡的高口腔液暴露机制以减少龋齿
  • 批准号:
    10765181
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Examining injectable buprenorphine implementation strategies in low-threshold and primary care settings
检查低阈值和初级保健环境中注射丁丙诺啡的实施策略
  • 批准号:
    10591424
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine.
具有处方阿片类药物依赖性的提供者和老年疼痛患者:一项定性研究,旨在了解阿片类药物逐渐减少、戒断和过渡到丁丙诺啡的障碍。
  • 批准号:
    10671358
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Building and Implementing Best Practices for Buprenorphine Initiation in the Setting of Fentanyl Use
在芬太尼使用情况下建立和实施丁丙诺啡起始的最佳实践
  • 批准号:
    10721763
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Long acting biodegradable buprenorphine depots
长效可生物降解丁丙诺啡储库
  • 批准号:
    10757180
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).
标准和高剂量 ED 丁丙诺啡诱导。
  • 批准号:
    10938754
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
FY23. TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/24.
23 财年。
  • 批准号:
    10938755
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Understanding the Association between Sublingual Buprenorphine and Oral Health Outcomes
了解舌下含服丁丙诺啡与口腔健康结果之间的关联
  • 批准号:
    10765299
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
舌下含服与缓释丁丙诺啡对离开监狱环境的个体的有效性比较试验
  • 批准号:
    10718889
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)
添加丁丙诺啡、认知行为治疗和经颅磁刺激以改善长期阿片类药物治疗慢性疼痛的效果的序贯试验 (ACTION)
  • 批准号:
    10717184
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了